Charter Life Sciences
Venture capital · Santa Clara, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio0 active
2Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Gossamer Bio
9Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Gossamer Bio | Biotech | Public | Sep 4, 2026 | $728.1M |
| Aravive | Biotech | Closed | Oct 28, 2022 | $156.1M |
| Atara Biotherapeutics | Biotech | Public | — | — |
Peer ranks
Portfolio size#136
Portfolio exits#103
Raises, 12 months#22
Co-investors#165
Co-investors
- Atlas VentureVenture capital1 shared
- Domain AssociatesVenture capital1 shared
- Lightstone VenturesVenture capital1 shared
- Longitude CapitalVenture capital1 shared
- Novaquest Capital ManagementVenture capital1 shared
- PJCVenture capital1 shared
- Telegraph Hill PartnersVenture capital1 shared
- Thomas, McNerney & PartnersVenture capital1 shared
- Versant VenturesVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.